false
0001173281
0001173281
2023-12-27
2023-12-27
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current
Report
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported):
December 27, 2023
NeuBase Therapeutics, Inc.
(Exact Name of Registrant as Specified in Its
Charter)
| Delaware |
|
001-35963 |
|
46-5622433 |
(State
or Other Jurisdiction
of Incorporation) |
|
(Commission
File Number) |
|
(I.R.S.
Employer
Identification No.) |
| 350
Technology Drive, Pittsburgh,
PA |
|
15219 |
| (Address
of Principal Executive Offices) |
|
(Zip Code) |
| (412)
763-3350 |
| (Registrant’s
Telephone Number, Including Area Code) |
| N/A |
(Former
Name or Former Address, if Changed Since
Last Report) |
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ¨ | Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title
of each class |
Trading
Symbol(s) |
Name
of each exchange on which registered |
| Common
Stock, par value $0.0001 per share |
NBSE |
The
Nasdaq Stock Market LLC |
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (17 CFR § 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934
(17 CFR § 240.12b-2).
Emerging growth company ¨
If an emerging growth company, indicate
by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Item
1.02 Termination of a Material Definitive Agreement.
On December 27, 2023, NeuBase Therapeutics, Inc. (the “Company”)
entered into (i) a Lease Termination and Mutual Release Agreement (the “Lease Termination and Mutual Release Agreement”) with
350 Technology Drive Partners, LLC, a Pennsylvania limited liability company (the “Landlord”), and (ii) a Bill of Sale (the
“Bill of Sale”) for the benefit of University of Pittsburgh of the Commonwealth System of Higher Education, a Pennsylvania
non-profit corporation (the “University of Pittsburgh”), in each case in connection with the termination (the “Lease
Termination”) of the Lease Agreement, dated October 2, 2020, by and between the Company and the Landlord, as amended by the First
Amendment to Lease Agreement, dated December 28, 2020, by and between the Company and the Landlord, and the Second Amendment to Lease
Agreement, dated April 21, 2021, by and between the Company and the Landlord (the “Lease Agreement”), in connection with the
premises located at Suite 421, 350 Technology Drive, Pittsburgh, PA 15219 (the “Premises”). Pursuant to the Lease Termination
and Mutual Release Agreement, the Company and the Landlord agreed to terminate the Lease Agreement, effective as of February 29, 2024
(the “Lease Termination Date”), subject to the terms and conditions therein. The Lease Termination and Mutual Release Agreement
provides that the Company shall surrender the Premises on or prior to January 31, 2024 and shall have no further rent obligations after
the Lease Termination Date.
As consideration for the Landlord’s agreement to terminate the
Lease Agreement as of the Lease Termination Date, the Company agreed to pay the Landlord a lease termination fee (the “Lease Termination
Fee”) of $1,550,000 and enter into the Bill of Sale, which conveys to the University of Pittsburgh the furniture, fixtures and equipment
currently located in the Premises pursuant to the terms and conditions therein. The Lease Termination Fee shall be due on the later of
(i) within five (5) business days following the date of the Lease Termination and Mutual Release Agreement and (ii) January 5, 2024.
In addition, the Company agreed to pay the Landlord’s sole listing
agent for the Premises a commission of approximately $178,000 in connection with its services relating to the Lease Termination, which
payment is due on the later of (i) within five (5) business days following the date of the Lease Termination and Mutual Release Agreement
and (ii) January 5, 2024.
The foregoing descriptions of the Lease Termination and Mutual Release
Agreement and the Bill of Sale are not complete and are qualified in their entirety by references to the full text of the Lease Termination
and Mutual Release Agreement and the Bill of Sale, respectively, copies of which are filed as exhibits
to this Current Report on Form 8-K and are incorporated by reference herein.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| |
NEUBASE THERAPEUTICS, INC. (Registrant) |
| |
|
| Date: December 28, 2023 |
By: |
/s/ Todd P. Branning |
| |
|
Todd P. Branning |
| |
|
Chief Financial Officer |
| |
|
(Principal Financial and Accounting Officer) |
Exhibit 10.1
LEASE TERMINATION AND MUTUAL RELEASE AGREEMENT
THIS
LEASE TERMINATION AND MUTUAL RELEASE AGREEMENT (this “Agreement”) is made as of this 27 day of December, 2023 (the
“Effective Date”), by and between 350 TECHNOLOGY DRIVE PARTNERS, LLC, a Pennsylvania limited liability company
(“Landlord”), and NEUBASE THERAPEUTICS, INC., a Delaware corporation (“Tenant”).
RECITALS
WHEREAS,
Landlord and Tenant are parties to that certain Lease Agreement dated as of October 2, 2020, as amended by that certain letter agreement
dated as of December 28, 2020, as further amended by that certain First Amendment to Lease Agreement dated as of December 28,
2020, and as further amended by that certain Second Amendment to Lease Agreement dated as of April 21, 2021 (collectively, the “Lease”),
pursuant to which Tenant leases from Landlord that certain space consisting of approximately fourteen thousand one hundred eighty-nine
(14,189) rentable square feet known as Suite 421 (the “Leased Premises”) in the building located at 350 Technology
Drive, Pittsburgh, PA 15219; and
WHEREAS, Landlord
and Tenant have agreed to terminate and cancel the Lease earlier than its scheduled expiration date upon the terms and conditions set
forth herein.
NOW, THEREFORE,
in consideration of the mutual promises and undertakings of the parties as set forth herein, and for other good and valuable consideration,
the receipt and legal sufficiency of which is hereby acknowledged, the parties, intending to be legally bound, hereto covenant and agree
as follows:
1. Recitals;
Defined Terms. The foregoing recitals are incorporated into the body of this Agreement as if the same were fully set forth
herein. All capitalized terms used herein but not otherwise defined herein shall have the meanings ascribed thereto in the Lease.
2. Lease
Termination. The Lease Term shall expire, and the Lease shall be deemed to be terminated, on February 29, 2024, at 11:59
p.m. (the “Lease Termination Date”).
3. Lease
Termination Payment. In consideration of Landlord’s agreement to terminate the Lease as of the Lease Termination
Date, Tenant shall (i) pay to Landlord a lease termination fee equal to One Million Five Hundred Fifty Thousand and 00/100
Dollars ($1,550,000.00) (the “Lease Termination Fee”), and (ii) simultaneously with the execution and
delivery of this Agreement, execute and deliver to Landlord the Bill of Sale in the form that is attached hereto as Exhibit A
(the “Bill of Sale”) that conveys to the University of Pittsburgh (the “University”) all of
the furniture, fixtures and equipment currently located in the Premises (the “FF&E”), as such FF&E is
listed in Schedule A to the Bill of Sale, upon the terms and conditions set forth in the Bill of Sale. The Lease Termination Payment
shall be due, payable, and paid by Tenant to Landlord on the later of (i) January 5, 2024, or (ii) within five
(5) Business Days following the Effective Date.
4. Obligations;
Surrender of Premises; Security Deposit. From and after the Effective Date until the Lease Termination Date, Landlord and
Tenant shall abide by all terms and conditions set forth in the Lease, including, without limitation, Tenant’s obligation to pay Rent
for the months of January and February, 2024. Tenant’s monthly obligations for Annual Base Rent, Increases in Real Estate Taxes, Increases
in Operating Costs, and Electric Charges for January of 2024 shall be due and payable in accordance with and at the times required
in the Lease. Tenant’s monthly obligations for Annual Base Rent, Increases in Real Estate Taxes, Increases in Operating Costs,
and Electric Charges for February of 2024 (collectively, “February Rent”) shall be applied against the Security
Deposit and retained by Landlord. On or prior to January 31, 2024 (the “Surrender Date”), Tenant shall surrender
the Leased Premises to Landlord broom clean and in good condition and repair (reasonable wear and tear and damage by casualty excepted),
with all of Tenant’s personal property removed from the Leased Premises, except for the FF&E and Tenant’s generator solely dedicated
to the Leased Premises, which FF&E and generator shall remain in the Leased Premises. Such generator is being transferred to Landlord
pursuant to this Agreement “AS IS, WHERE-IS,” with all faults and without warranty of any kind, express or implied, including
any warranty of merchantability or fitness for any particular purpose. Provided Tenant surrenders the Leased Premises on or prior to
the Surrender Date, Landlord shall return the Security Deposit in the amount of One Hundred Twenty-Five Thousand Three Hundred Ninety-One
and 44/100 Dollars ($125,391.44), less the amount for February Rent, to Tenant within thirty (30) days following the Lease Termination
Date. If Tenant fails to comply with the obligations set forth in this Section 4 (including not satisfying the surrender
condition of the Leased Premises), Landlord may apply the Security Deposit in accordance with the Lease. No later than ten (10) days
prior to the Lease Termination Date, Landlord shall submit to Tenant the statement required under Section 3.4(b) of the Lease
setting forth the actual amount of Increases in Real Estate Taxes and Increases in Operating Costs for the 2023 calendar year. If Tenant’s
Pro Rata Share of the actual amount of Increases in Real Estate Taxes and Increases in Operating Costs, as applicable, for the 2023 calendar
year are greater than the estimated amounts paid by Tenant with respect thereto, the excess amount owed by Tenant with respect thereto
shall be deducted from the remaining Security Deposit and retained by Landlord. If Tenant’s Pro Rata Share of the actual amount of Increases
in Real Estate Taxes and Increases in Operating Costs for the 2023 calendar year shall be less than the estimated amounts paid by Tenant,
Landlord shall return such overpaid amount, together with the remaining Security Deposit, to Tenant within thirty (30) days following
the Lease Termination Date. Landlord and Tenant acknowledge and agree that there shall be no reconciliation with respect to Tenant’s
payments of Increases in Real Estate Taxes and Operating Costs or Electric Charges for the months of January and February, 2024.
Tenant acknowledges and agrees that Landlord intends to enter into a lease agreement with the University pursuant to which the University
will lease the Leased Premises from Landlord commencing as of March 1, 2024. Tenant agrees that the University may enter and access
the Leased Premises any time following the Surrender Date for the purpose of installing the University’s fixtures, furniture, and equipment,
including without limitation, cabling, wiring and telephone equipment. From and after the Surrender Date, Tenant shall not have any responsibility
to maintain or secure the Leased Premises, nor shall Tenant have any liability or obligations with respect to any, and Tenant shall be
indemnified by Landlord for any, damages occurring in or to the Leased Premises from and after the Surrender Date, except to the extent
such damages are the result of Tenant’s negligence or willful misconduct or events or damages first occurring prior to the Surrender
Date. Additionally, from and after the Effective Date, upon receipt of request therefor from the University, Landlord and Tenant shall
cooperate with the University to allow the University to gain access to the Leased Premises for the purpose of inspecting the same in
order to plan for its occupancy.
5. Survival. The
parties hereto covenant and agree that effective and simultaneously with the termination of the Lease on the Lease Termination Date,
Landlord and Tenant shall have no further rights, duties and obligations pursuant to the Lease, except for those certain obligations
set forth in Section 9 of the Lease with respect to matters first occurring prior to the Lease Termination Date.
Notwithstanding anything contained herein to the contrary, in the event Tenant fails to pay any Rent or surrender possession of the
Leased Premises on or prior to the Surrender Date in the condition required by this Agreement, Landlord shall have the right to take
any and all action to which it is entitled under the Lease or otherwise. In the event Landlord is required to bring an action to
enforce the terms of this Agreement or the Lease and prevails in such action, Tenant shall be responsible for paying all of
Landlord’s costs and expenses (including reasonable attorneys’) that are incurred by Landlord in connection with the enforcement of
this Agreement or the Lease.
6. Release
and Discharge.
(a) Subject
to Tenant fulfilling its obligations under Sections 3, 4 and 7 hereof, upon the Lease Termination Date, Landlord for itself, and for its
parents, subsidiaries, directors, officers, shareholders, partners, members, employees, servants, insurers, sureties, agents, attorneys,
representatives, successors and assigns, does hereby RELEASE AND FOREVER DISCHARGE Tenant from any and all claims, demands, damages, obligations,
controversies, causes of action, suits, judgments, accounts, debts, liens, costs, fees, bills and expenses (including, without limitation,
all legal fees, interest, or penalties) of every kind, name, nature, and description whether arising out of contract, tort, or otherwise,
in law or equity, of whatsoever kind or nature, whether liquidated or unliquidated, matured or unmatured, known or unknown, suspected
or unsuspected, relating to this Agreement, the Lease, or the Leased Premises.
(b) Subject
to Landlord fulfilling its obligation to return the Security Deposit to Tenant and make such other payments to Tenant in accordance with
Section 4 hereof, upon the Lease Termination Date, Tenant for itself, and for its parents, subsidiaries, directors, officers, shareholders,
partners, members, employees, servants, insurers, sureties, agents, attorneys, representatives, successors and assigns, does hereby RELEASE
AND FOREVER DISCHARGE Landlord from any and all claims, demands, damages, obligations, controversies, causes of action, suits, judgments,
accounts, debts, liens, costs, fees, bills and expenses (including, without limitation, all legal fees, interest, or penalties) of every
kind, name, nature, and description whether arising out of contract, tort, or otherwise, in law or equity, of whatsoever kind or nature,
whether liquidated or unliquidated, matured or unmatured, known or unknown, suspected or unsuspected, relating to this Agreement, the
Lease, or the Leased Premises.
7. Brokerage
Commissions. Landlord and Tenant each represent and warrant to the other that there were no real estate agents or brokers involved
with the negotiation and execution of this Agreement other than Burns Scalo Brokerage LLC (“Landlord’s Broker”),
on behalf of Landlord, and Hanna Langholz Wilson Ellis (“Tenant’s Broker”), on behalf of Tenant. Tenant hereby
agrees to pay Landlord’s Broker and Tenant’s Broker any commissions due as a result of this Agreement in accordance with Tenant’s separate
agreements with such parties. Landlord and Tenant shall each hold the other harmless from any claims for commissions, fees or compensation
for this Agreement by any other person or entity claiming to have acted as agent, representative or broker for any of the parties to
this Agreement. The terms of this Section 7 shall survive the expiration or earlier termination of the Lease.
8. Miscellaneous. (a) Each
of Landlord and Tenant hereby represent and warrant to the other that it has the full right and authority to enter into this
Agreement and that its respective signatory is fully and properly authorized to execute this Agreement on behalf of Landlord or
Tenant, as applicable. (b) This Agreement shall be binding upon Landlord, Tenant and their respective successors and assigns.
(c) This Agreement shall be governed by and construed in accordance with the substantive laws of the Commonwealth of
Pennsylvania (without reference to its principles of conflicts of laws). (d) It is understood and agreed that this Agreement
may be executed in several counterparts, each of which shall, for all purposes, be deemed an original and all of such counterparts,
taken together, shall constitute one and the same agreement, even though all of the parties may not have executed the same
counterpart of this Agreement. A fully-executed e-mailed copy of this Agreement shall be deemed original for all relevant purposes.
(e) This Agreement may not be amended or modified except in writing executed by all of the parties hereto. (f) No waiver
of any provision or condition of this Agreement by any party hereto shall be valid unless in writing signed by such party. No such
waiver shall be taken as a waiver of any other or similar provision or of any further event, act or default. (g) Headings of
the sections of this Agreement are for convenience of reference only and shall not be construed as part of this Agreement.
(i) If any term or provision of this Agreement, or application thereof to any person or circumstances, shall, to any extent, be
found by a court of competent jurisdiction to be invalid or unenforceable, the remainder of this Agreement, or the application or
such term or provision to persons or circumstances other than those as to which it is held invalid or unenforceable, shall not be
affected thereby and each other term or provision of this Agreement shall be valid and be enforced to the fullest extent permitted
by law. (j) Each party had counsel review this Agreement or had the opportunity to do so and this Agreement shall not be
construed against either party as a result of who prepared it. (k) In the event of any conflict between the terms of the Lease
and those of this Agreement, the terms of this Agreement shall prevail.
[REMAINDER OF THIS PAGE INTENTIONALLY LEFT BLANK]
IN WITNESS WHEREOF, the parties
hereto entered into this Agreement as of the day and year first above written.
| |
LANDLORD: |
| |
|
|
| |
350 TECHNOLOGY DRIVE PARTNERS, LLC, a Pennsylvania limited liability company |
| |
By: TBV Manger, LLC, a Pennsylvania limited liability company, its sole manager |
| |
|
|
| |
By: |
/s/ James D. Scalo |
| |
|
James D. Scalo, Sole Member |
| |
|
|
| |
TENANT: |
| |
|
|
| |
NEUBASE THERAPEUTICS, INC., a Delaware corporation |
| |
|
|
| |
By: |
/s/ Dietrich Stephan |
| |
Name: |
Dietrich Stephan |
| |
Tile: |
CEO |
EXHIBIT A
Bill of Sale
[Attached]
BILL OF SALE
THIS
BILL OF SALE (this “Bill of Sale”) is dated as of this __________ day of ___________, 2023, by NEUBASE THERAPEUTICS, INC.,
a Delaware corporation (the “Transferor”) for the benefit of UNIVERSITY OF PITTSBURGH-OF THE COMMONWEALTH SYSTEM OF
HIGHER EDUCATION, a Pennsylvania non-profit corporation (the “Transferee”).
WITNESSETH:
WHEREAS, Transferor and 350
Technology Drive Partners, LLC (“Landlord”) are parties to that certain Lease Agreement dated as of October 2,
2020, as amended by that certain letter agreement dated as of December 28, 2020, as further amended by that certain First Amendment
to Lease Agreement dated as of December 28, 2020, and as further amended by that certain Second Amendment to Lease Agreement dated
as of April 21, 2021 (collectively, the “Neubase Lease”), pursuant to which Landlord leases to Transferor that
certain space consisting of approximately fourteen thousand one hundred eighty-nine (14,189) rentable square feet known as Suite 421
(the “Premises”) in Landlord’s building located at 350 Technology Drive, Pittsburgh, PA 15219; and
WHEREAS, Transferor and Landlord
have entered into that certain Lease Termination Agreement dated as of even date herewith (the “Lease Termination Agreement”),
pursuant to which, inter alia, Transferor and Landlord have agreed to terminate the Neubase Lease effective as of 11:59 p.m. on
February 29, 2024 (the “Termination Date”); and
WHEREAS, Landlord and Transferee
entered into that certain Lease Agreement dated as of even date herewith (the “Transferee Lease”) pursuant to which,
inter alia, Landlord will lease the Premises to Transferee commencing as of March 1, 2024; provided, Landlord has granted
Transferee early access to the Premises commencing as of February 1, 2024 (the “Transfer Date”); and
WHEREAS, as a condition to
Landlord entering into the Lease Termination Agreement and agreeing to terminate the Lease, Transferor has agreed to, inter alia,
transfer to Transferee on the Transfer Date all of the furniture, fixtures and equipment located in the Premises as of the date hereof
(collectively, the “FF&E”), as such FF&E is listed in Schedule A attached hereto and made a part hereof;
and
WHEREAS, Transferee desires to accept the FF&E on the
Transfer Date.
NOW, THEREFORE, Transferor,
for and in consideration of One Dollar ($1.00), and for other good and valuable consideration, the receipt and legal sufficiency of which
are hereby acknowledged, does hereby absolutely and unconditionally grant, bargain, sell, transfer, assign and deliver unto Transferee
on the Transfer Date all of Transferor’s right, title and interest in and to the FF&E. Transferor hereby represents and warrants to
Transferee that (i) Transferor is the true and lawful owner of the FF&E as of the date hereof and will be the lawful owner of
the FF&E on the Transfer Date, (ii) Transferor has the legal right to transfer the FF&E to Transferee on the Transfer Date,
and (iii) the FF&E is being transferred to Transferee on the Transfer Date free and clear of any liens, restrictions, leases,
security interests, claims, charges, mortgages, or encumbrances of any kind. Transferee acknowledges and agrees that, except as provided
in the immediately preceding sentence, Transferor makes no representations or warranties to Transferee regarding the FF&E and the
FF&E is transferred to Transferee on an "as is" basis. Transferor shall not remove any of the FF&E from the Neubase
Premises on or prior to the Transfer Date. Except as otherwise set forth herein, the FF&E is being transferred to Transferee AS IS,
WHERE-IS, with all faults and without warranty of any kind, express or implied, including any warranty of merchantability or fitness for
any particular purpose.
TO HAVE AND TO HOLD the FF&E
unto Transferee, its successors and assigns, to its own use and benefit forever.
[Signature Page Follows]
IN
WITNESS WHEREOF, an intending to be legally bound hereby, Transferor has executed this Bill of Sale as of this ______ day
of __________________, 2023.
| |
NEUBASE THERAPEUTICS, INC., a Delaware corporation |
| |
|
| |
|
| |
By: |
|
| |
Name: |
|
| |
Title: |
|
| |
|
| |
|
| |
UNIVERSITY OF PITTSBURGH-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION, a Pennsylvania non-profit corporation |
| |
|
| |
|
| |
By: |
|
| |
Name: |
|
| |
Title: |
|
SCHEDULE
A
FF&E
Chem Lab
| Hoods |
9 Chemical Fume Hoods |
| Benching |
207 LF |
Bio Lab
| Hoods |
1 Fume Hood |
| Benching |
226 LF |
| Table |
one rolling |
| Chairs |
8 rolling |
Tissue Culture Room
| Hoods |
4 Tissue Culture Hoods |
| Benching |
24 LF |
Utility/Freezer Room
None
Kitchen
Furniture
1 kitchen style table
3 chairs
1 hightop table
3 bar height chairs
Appliances
2 full size refrigerators
1 toaster oven
2 microwaves
1 coffee maker
IT Room
Misc. racks
Office Area
Offices - 8
8 desks
8 desk chairs
16 guest chairs
4 credenzas
8 file cabinets
Work Stations - 4
Four 6-person star shaped
24 chairs
one 6-person bench
6 hightop bench chairs
19 Filing Cabinets
2 portable whiteboards
Conference Room
one table
15 chairs
75" Screen
Huddle #1
One round table
6 chairs
60" screen
Huddle #2
one oval table
5 hightop chairs
60" screen
Huddle #3
couch
3 chairs
small coffee table
1 side table
60" screen
Open area
5 chairs
2 love seats
4 small coffee tables
Miscellaneous
8 lab chairs
2 eyewash stations
Wine refrigerator
Small refrigerator with beer taps
2 dishwashers
2 small laptop tables
Several whiteboards attached to walls
Exhibit 10.2
BILL OF SALE
THIS BILL OF SALE (this “Bill
of Sale”) is dated as of this 27th day of December, 2023, by NEUBASE THERAPEUTICS, INC., a Delaware corporation (the “Transferor”)
for the benefit of UNIVERSITY OF PITTSBURGH-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION, a Pennsylvania non-profit corporation (the
“Transferee”).
WITNESSETH:
WHEREAS, Transferor and 350
Technology Drive Partners, LLC (“Landlord”) are parties to that certain Lease Agreement dated as of October 2, 2020,
as amended by that certain letter agreement dated as of December 28, 2020, as further amended by that certain First Amendment to
Lease Agreement dated as of December 28, 2020, and as further amended by that certain Second Amendment to Lease Agreement dated as
of April 21, 2021 (collectively, the “Neubase Lease”), pursuant to which Landlord leases to Transferor that certain
space consisting of approximately fourteen thousand one hundred eighty-nine (14,189) rentable square feet known as Suite 421 (the
“Premises”) in Landlord’s building located at 350 Technology Drive, Pittsburgh, PA 15219; and
WHEREAS, Transferor and Landlord
have entered into that certain Lease Termination Agreement dated as of even date herewith (the “Lease Termination Agreement”),
pursuant to which, inter alia, Transferor and Landlord have agreed to terminate the Neubase Lease effective as of 11:59 p.m. on
February 29, 2024 (the “Termination Date”); and
WHEREAS, Landlord and Transferee
entered into that certain Lease Agreement dated as of even date herewith (the “Transferee Lease”) pursuant to which,
inter alia, Landlord will lease the Premises to Transferee commencing as of March 1, 2024; provided, Landlord has granted
Transferee early access to the Premises commencing as of February 1, 2024 (the “Transfer Date”); and
WHEREAS, as a condition to
Landlord entering into the Lease Termination Agreement and agreeing to terminate the Lease, Transferor has agreed to, inter alia, transfer
to Transferee on the Transfer Date all of the furniture, fixtures and equipment located in the Premises as of the date hereof (collectively,
the “FF&E”), as such FF&E is listed in Schedule A attached hereto and made a part hereof; and
WHEREAS, Transferee desires
to accept the FF&E on the Transfer Date.
NOW, THEREFORE, Transferor,
for and in consideration of One Dollar ($1.00), and for other good and valuable consideration, the receipt and legal sufficiency of which
are hereby acknowledged, does hereby absolutely and unconditionally grant, bargain, sell, transfer, assign and deliver unto Transferee
on the Transfer Date all of Transferor’s right, title and interest in and to the FF&E. Transferor hereby represents and warrants to
Transferee that (i) Transferor is the true and lawful owner of the FF&E as of the date hereof and will be the lawful owner of
the FF&E on the Transfer Date, (ii) Transferor has the legal right to transfer the FF&E to Transferee on the Transfer Date,
and (iii) the FF&E is being transferred to Transferee on the Transfer Date free and clear of any liens, restrictions, leases,
security interests, claims, charges, mortgages, or encumbrances of any kind. Transferee acknowledges and agrees that, except as provided
in the immediately preceding sentence, Transferor makes no representations or warranties to Transferee regarding the FF&E and the
FF&E is transferred to Transferee on an “as is” basis. Transferor shall not remove any of the FF&E from the Neubase
Premises on or prior to the Transfer Date. Except as otherwise set forth herein, the FF&E is being transferred to Transferee AS IS,
WHERE-IS, with all faults and without warranty of any kind, express or implied, including any warranty of merchantability or fitness for
any particular purpose.
TO HAVE AND TO HOLD the FF&E
unto Transferee, its successors and assigns, to its own use and benefit forever.
[Signature Page Follows]
IN WITNESS WHEREOF, an intending to be legally
bound hereby, Transferor has executed this Bill of Sale as of this 27th day of December, 2023.
| |
NEUBASE THERAPEUTICS, INC., a Delaware corporation |
| |
|
| |
|
| |
By: |
/s/ Dietrich Stephan |
| |
Name: |
Dietrich Stephan |
| |
Title: |
CEO |
| |
|
| |
|
| |
UNIVERSITY OF PITTSBURGH-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION, a Pennsylvania non-profit corporation |
| |
|
| |
|
| |
By: |
/s/ David N. DeJong |
| |
Name: |
David N. DeJong |
| |
Title: |
Senior Vice Chancellor for Business and Operations |
SCHEDULE A
FF&E
| Chem Lab |
|
| |
|
| Hoods |
9 Chemical Fume Hoods |
| Benching |
207 LF |
| |
|
| Bio Lab |
|
| |
|
| Hoods |
1 Fume Hood |
| Benching |
226 LF |
| Table |
one rolling |
| Chairs |
8 rolling |
| |
|
| Tissue Culture Room |
|
| |
|
| Hoods |
4 Tissue Culture Hoods |
| Benching |
24 LF |
| |
|
| Utility/Freezer Room |
|
| |
|
| None |
|
| |
|
| Kitchen |
|
| |
|
| Furniture |
|
| |
1 kitchen style table |
| |
3 chairs |
| |
1 hightop table |
| |
3 bar height chairs |
| |
|
| Appliances |
|
| |
2 full size refrigerators |
| |
1 toaster oven |
| |
2 microwaves |
| |
1 coffee maker |
| IT Room |
|
| |
Misc. racks |
| Office Area |
|
| |
|
| Offices - 8 |
|
| |
8 desks |
|
8 desk chairs |
| |
16 guest chairs |
| |
4 credenzas |
| |
8 file cabinets |
| Work Stations - 4 |
|
| |
Four 6-person star shaped |
| |
24 chairs |
| |
one 6-person bench |
| |
6 hightop bench chairs |
| |
19 Filing Cabinets |
| |
2 portable whiteboards |
| |
|
| Conference Room |
|
| |
one table |
| |
15 chairs |
| |
75” Screen |
| |
|
| Huddle #1 |
|
| |
One round table |
| |
6 chairs |
| |
60” screen |
| |
|
| Huddle #2 |
|
| |
one oval table |
| |
5 hightop chairs |
| |
60” screen |
| |
|
| Huddle #3 |
|
| |
couch |
| |
3 chairs |
| |
small coffee table |
| |
1 side table |
| |
60” screen |
| |
|
| Open area |
|
| |
5 chairs |
| |
2 love seats |
| |
4 small coffee tables |
| |
|
| Miscellaneous |
|
| |
8 lab chairs |
| |
2 eyewash stations |
| |
Wine refrigerator |
| |
Small refrigerator with beer taps |
| |
2 dishwashers |
| |
2 small laptop tables |
| |
Several whiteboards attached to walls |
v3.23.4
| X |
- DefinitionBoolean flag that is true when the XBRL content amends previously-filed or accepted submission.
| Name: |
dei_AmendmentFlag |
| Namespace Prefix: |
dei_ |
| Data Type: |
xbrli:booleanItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionFor the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.
| Name: |
dei_DocumentPeriodEndDate |
| Namespace Prefix: |
dei_ |
| Data Type: |
xbrli:dateItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionThe type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
| Name: |
dei_DocumentType |
| Namespace Prefix: |
dei_ |
| Data Type: |
dei:submissionTypeItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionAddress Line 1 such as Attn, Building Name, Street Name
| Name: |
dei_EntityAddressAddressLine1 |
| Namespace Prefix: |
dei_ |
| Data Type: |
xbrli:normalizedStringItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- Definition
+ References
+ Details
| Name: |
dei_EntityAddressCityOrTown |
| Namespace Prefix: |
dei_ |
| Data Type: |
xbrli:normalizedStringItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionCode for the postal or zip code
| Name: |
dei_EntityAddressPostalZipCode |
| Namespace Prefix: |
dei_ |
| Data Type: |
xbrli:normalizedStringItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionName of the state or province.
| Name: |
dei_EntityAddressStateOrProvince |
| Namespace Prefix: |
dei_ |
| Data Type: |
dei:stateOrProvinceItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionA unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK. Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
| Name: |
dei_EntityCentralIndexKey |
| Namespace Prefix: |
dei_ |
| Data Type: |
dei:centralIndexKeyItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionIndicate if registrant meets the emerging growth company criteria. Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
| Name: |
dei_EntityEmergingGrowthCompany |
| Namespace Prefix: |
dei_ |
| Data Type: |
xbrli:booleanItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionCommission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.
| Name: |
dei_EntityFileNumber |
| Namespace Prefix: |
dei_ |
| Data Type: |
dei:fileNumberItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionTwo-character EDGAR code representing the state or country of incorporation.
| Name: |
dei_EntityIncorporationStateCountryCode |
| Namespace Prefix: |
dei_ |
| Data Type: |
dei:edgarStateCountryItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionThe exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC. Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
| Name: |
dei_EntityRegistrantName |
| Namespace Prefix: |
dei_ |
| Data Type: |
xbrli:normalizedStringItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionThe Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS. Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
| Name: |
dei_EntityTaxIdentificationNumber |
| Namespace Prefix: |
dei_ |
| Data Type: |
dei:employerIdItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionLocal phone number for entity.
| Name: |
dei_LocalPhoneNumber |
| Namespace Prefix: |
dei_ |
| Data Type: |
xbrli:normalizedStringItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act. Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 13e
-Subsection 4c
| Name: |
dei_PreCommencementIssuerTenderOffer |
| Namespace Prefix: |
dei_ |
| Data Type: |
xbrli:booleanItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act. Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 14d
-Subsection 2b
| Name: |
dei_PreCommencementTenderOffer |
| Namespace Prefix: |
dei_ |
| Data Type: |
xbrli:booleanItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionTitle of a 12(b) registered security. Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b
| Name: |
dei_Security12bTitle |
| Namespace Prefix: |
dei_ |
| Data Type: |
dei:securityTitleItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionName of the Exchange on which a security is registered. Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection d1-1
| Name: |
dei_SecurityExchangeName |
| Namespace Prefix: |
dei_ |
| Data Type: |
dei:edgarExchangeCodeItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act. Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Section 14a
-Number 240
-Subsection 12
| Name: |
dei_SolicitingMaterial |
| Namespace Prefix: |
dei_ |
| Data Type: |
xbrli:booleanItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionTrading symbol of an instrument as listed on an exchange.
| Name: |
dei_TradingSymbol |
| Namespace Prefix: |
dei_ |
| Data Type: |
dei:tradingSymbolItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act. Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Securities Act
-Number 230
-Section 425
| Name: |
dei_WrittenCommunications |
| Namespace Prefix: |
dei_ |
| Data Type: |
xbrli:booleanItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
NeuBase Therapeutics (NASDAQ:NBSE)
Historical Stock Chart
From Apr 2024 to May 2024
NeuBase Therapeutics (NASDAQ:NBSE)
Historical Stock Chart
From May 2023 to May 2024
